Targeting autophagy enhances the anticancer effect of artemisinin and its derivatives

Author:

Sun Xin1,Yan Peiyi2,Zou Chang3,Wong Yin‐Kwan4,Shu Yuhan5,Lee Yew Mun4,Zhang Chongjing6,Yang Nai‐Di4,Wang Jigang3478,Zhang Jianbin1ORCID

Affiliation:

1. Department of OncologyZhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College Hangzhou China

2. Department of Clinical LaboratoryShanghai Putuo District People's Hospital Shanghai China

3. Clinical Medical Research CenterThe Second Clinical Medical College of Jinan University, The First Affiliated Hospital of Southern University, Shenzhen Public Service Platform on Tumor Precision Medicine and Molecular Diagnosis, Shenzhen People's Hospital Shenzhen China

4. Department of Pharmacology, Department of Physiology, Yong Loo Lin School of MedicineNational University of Singapore Singapore Singapore

5. College of Biomedical Engineering & Instrument ScienceZhejiang University Hangzhou China

6. Institute of Material MedicalPeking Union Medical College Beijing China

7. Artemisinin Research CenterInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing China

8. Key Laboratory of Cardio‐Cerebrovascular Disease Prevention & TherapyGannan Medical University Ganzhou China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Zhejiang Province

Publisher

Wiley

Subject

Drug Discovery,Pharmacology,Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3